Chymosin: A Review of Molecular Features, Coagulation Kinetics, and Activity Evaluation
Chymosin: A Review of Molecular Features, Coagulation Kinetics, and Activity Evaluation
Chymosin (also known as rennin) is one of the most representative milk-clotting enzyme preparations used in cheese manufacturing and in studies of milk-protein colloids. It is an aspartic protease. Its key reaction in milk is the highly site-specific hydrolysis of κ-casein, with the canonical cleavage occurring between Phe105 and Met106. This cleavage yields para-κ-casein and the hydrophilic glycomacropeptide (GMP), which weakens the stabilizing surface barrier of casein micelles and triggers Ca2+-mediated micellar aggregation, ultimately forming a rennet gel network. Chymosin combines milk-clotting capability with proteolytic activity: the former governs clotting time and gel-strength development, while the latter contributes to proteolysis during ripening and to flavor formation but may also increase risks of fragile gels, yield variability, and bitter-peptide generation. Accordingly, the source type of chymosin, the ratio of clotting activity to proteolytic activity, milk-salt equilibrium, and process-window control are core variables in R&D, quality control, and mechanistic studies of cheese and related fermented dairy products.
Keywords: chymosin; rennin; aspartic protease; κ-casein; Phe105–Met106; glycomacropeptide; casein micelle; coagulation kinetics; milk-clotting activity; cheese
I. Definition, Sources, and Formulation Types of Chymosin
1.1 Definition and functional positioning
(1) Chymosin refers to a protease system that induces destabilization of casein micelles and formation of a rennet gel network in milk. Its defining features are preferential site-specific cleavage of κ-casein and dependence on the milk-salt system (especially the effective availability of Ca2+).
(2) From a process perspective, chymosin determines clotting time, gel-strength build-up, and whey separation behavior. From a research perspective, it provides a tool-enabled entry point into a controllable phase-transition system of “site-specific hydrolysis–micellar destabilization–aggregation and gelation.”
1.2 Source categories and typical compositional differences
(1) Animal-derived rennet
① The traditional source is abomasal mucosal extract from unweaned calves. The active component is predominantly chymosin, commonly accompanied by a certain proportion of pepsin.
② Protease profiles and non-specific hydrolysis tendencies differ among animal sources, potentially leading to differences in ripening proteolysis pathways and flavor development.
(2) Microbial rennets
① These are typically fungal- or bacterial-derived rennet-like aspartic proteases that can achieve clotting, but often require tighter control with respect to broad proteolysis and bitter-peptide risk.
② In industrial use, practicability is often achieved by selecting strains with high clotting activity and low non-specific proteolysis, together with process optimization.
(3) Fermentation-produced recombinant chymosin
① Recombinant expression in microbial hosts yields high-purity chymosin, typically with a higher clotting-activity-to-proteolytic-activity ratio and more stable lot-to-lot consistency.
② For quality-sensitive cheese products, this can improve clotting stability and reduce flavor variability.
(1) Common product forms include liquid, powder, and tablet formulations. Powder products often provide higher activity concentration but impose higher requirements on reconstitution conditions and dosing uniformity.
(2) For research and process comparisons, dosing should be normalized by activity units and supported by lot-bridging calibration, rather than by volume or mass alone.
II. Molecular Basis of Action: Site-Specific κ-Casein Cleavage and Disruption of the Micellar Stabilizing Layer
2.1 Casein micelle structure and surface stabilization mechanisms
(1) Micellar components and inorganic phase:
Casein micelles are composed of αs1-, αs2-, β-, and κ-casein, together with colloidal calcium phosphate that contributes to a stable colloidal architecture.
(2) The “brush layer” role of κ-casein:
Κ-casein is enriched at the micellar surface. Its hydrophilic glycosylated region generates steric hindrance and electrostatic repulsion that suppress irreversible aggregation upon collision, serving as a primary stability barrier in milk.
2.2 Site-specific hydrolysis and structural consequences of products
(1) Preferred cleavage site:
Chymosin preferentially cleaves the κ-casein peptide bond between Phe105 and Met106, releasing the hydrophilic GMP while retaining the more hydrophobic para-κ-casein on the micellar surface.
(2) Direct consequence of barrier removal:
Removal of the hydrophilic segment sharply reduces surface stability, increasing susceptibility to hydrophobic aggregation and Ca2+ bridging among micelles.
(3) Threshold behavior in hydrolysis:
Once κ-casein cleavage reaches a critical fraction (often an empirical threshold around 80% or higher), the system enters a rapid aggregation window and gel network formation becomes pronounced.
III. Coagulation Kinetics: A Two-Stage Model and a Controllable Phase Transition
3.1 Stage 1: enzymatic hydrolysis
(1) Determinants of kinetics:
Enzyme concentration, temperature, pH, substrate accessibility, and inhibitory/competitive factors in milk collectively determine the site-cleavage rate.
(2) Process phenotype:
Primarily reflected as clotting time (from enzyme addition to detectable gelation signal) and the early rate of network emergence.
(3) Effects of heat treatment and protein interactions:
Whey-protein denaturation and interactions with κ-casein can reduce site accessibility or alter surface composition, delaying coagulation and reshaping gel microstructure.
3.2 Stage 2: non-enzymatic aggregation and gel network formation
(1) Aggregation drivers:
In the presence of Ca2+, micelles form a three-dimensional network via ionic bridging, hydrophobic interactions, and collision-driven aggregation, with gel strength increasing over time.
(2) Whey expulsion and contraction:
After gel formation, syneresis occurs and controls gel moisture, pore structure, and subsequent processing behavior.
(3) Role of cutting and timing:
The cutting time point and curd grain size determine surface area and drainage kinetics, influencing texture and yield.
3.3 Process significance of “clotting activity” and “proteolytic activity”
(1) Clotting activity governs coagulation rate and gelation efficiency and is central to front-end texture controllability.
(2) Proteolytic activity contributes to ripening flavor development and texture softening but can also increase risks of fragile gels, higher fines losses, and bitter-peptide accumulation when excessive.
(3) Enzyme preparations with high clotting activity and low non-specific proteolysis are better suited for products emphasizing flavor cleanliness and lot-to-lot consistency.
IV. Enzymological Properties and Stability: pH, Ionic Strength, and Conformational Sensitivity
4.1 Solubility and ionic-strength effects
(1) Chymosin solubility is influenced by pH, temperature, and ionic strength; within certain salt ranges, solubility may increase with ionic strength.
(2) Differences in salinity and pH between reconstitution media and the dosing system may cause local precipitation or activity loss; reconstitution and dispersion conditions should be validated in pilot tests.
4.2 pH stability range and activity-decay risk
(1) Stability is higher within an appropriate pH window; under stronger acidic conditions, autolysis may occur and reduce activity.
(2) Under alkaline conditions, irreversible conformational changes may reduce activity or cause inactivation; prolonged exposure to incompatible pH should be avoided.
4.3 Temperature-dependent inactivation and process windows
(1) Activity increases with temperature, but higher temperatures can accelerate inactivation and alter milk-protein conformations, narrowing operability for coagulation and cutting.
(2) In practice, a balanced window should be established among “enzymatic efficiency–culture temperature compatibility–cutting operability.”
V. Activity and Evaluation Methods: From Standard Units to Rheological Kinetics
5.1 Classical definition of milk-clotting activity
(1) Milk-clotting activity can be defined as the ability of a given amount of enzyme preparation to clot a standard milk substrate under specified temperature and time conditions, emphasizing comparability under standardized conditions.
(2) Liquid and powder formulations may have different nominal activity ranges; R&D and process development should prioritize unit-based calibration rather than empirical conversion between formulation types.
5.2 Curd strength and kinetic-curve characterization
(1) Clotting time:
Can be determined by tilting tests, visual inspection, optical scattering, ultrasound, or rheology (onset of G′ rise). A fixed decision criterion should be used across studies.
(2) Gel-strength build-up:
Monitor the G′ growth curve by rheology or use curd-tension instruments to quantify development rate and plateau strength, directly informing cutting time and drainage behavior.
(3) Proteolysis profiles:
Use SDS-PAGE, HPLC, or mass spectrometry to track κ-casein cleavage and non-specific proteolysis, providing mechanistic interpretation for texture differences and bitterness risk.
5.3 Applicability boundaries of typical strength-conversion approaches
(1) Some methods quantify clotting time in a standard milk substrate and convert it to clotting strength via formulae to enable rapid comparison of enzyme preparations or treatment conditions.
(2) Such methods are highly sensitive to milk composition, temperature, pH, and Ca2+ conditions; cross-lab or cross-batch comparisons require a fixed substrate system and inclusion of QC samples.
VI. Key Factors Affecting Coagulation Performance and Process Control
6.1 pH and acidity
(1) pH shifts casein charge state and the solubility of colloidal calcium phosphate, thereby changing micellar stability and Ca2+ availability. Small changes in raw-milk acidity can substantially shift the coagulation window.
(2) In fermented systems, acidification rate and chymosin dosing timing jointly determine gelation trajectories; a coupled time–pH–gel-strength control strategy is required.
6.2 Temperature and thermal history
(1) Milk temperature strongly affects coagulation speed and gel hardening rate. Higher temperatures generally accelerate coagulation, but overly rapid hardening can reduce controllability of cutting.
(2) Heat treatment denatures whey proteins and alters surface interactions with micelles, potentially extending clotting time and changing drainage behavior; compensation via Ca2+ adjustment and enzyme dosing may be needed.
6.3 Ca2+ concentration and milk-salt equilibrium
(1) Free Ca2+ is a key driver for micellar aggregation and gel network formation, influencing clotting time, curd firmness, and whey expulsion.
(2) CaCl2 addition is commonly used to restore clotting performance in heat-treated or low-Ca systems, but excessive addition may cause overly hard gels, overly rapid drainage, or abnormal texture; optimization should be guided by rheological curves and drainage behavior.
6.4 Milk composition: protein, fat, and homogenization effects
(1) Higher protein content generally increases gel network density and strength, but can also reshape drainage kinetics.
(2) Fat globules act as a filler phase influencing microstructure and porosity. Homogenization changes globule size and interfacial protein composition, potentially altering network connectivity and texture.
VII. Process Applications: Cheese Manufacturing and Texture Control in Fermented Dairy
7.1 Control logic in cheese production
(1) Dose and target clotting time:
Center on target clotting time and target gel-strength build-up curves; achieve lot-to-lot consistency via activity calibration and dose optimization.
(2) Cutting time point and grain size:
Cut after the gel reaches target strength; control curd grain size and stirring intensity to tune syneresis and moisture content.
(3) Ripening flavor management:
Non-specific proteolysis contributions from the enzyme preparation interact with ripening conditions to shape flavor and bitterness risk; front-end control should follow “minimum effective dose + preference for high-specificity preparations.”
7.2 Applicability boundaries in yogurt and related fermented-milk systems
(1) In systems dominated by acid gelation, chymosin typically functions as an auxiliary coagulation and texture-tuning tool, with effects strongly dependent on formulation and fermentation kinetics.
(2) When using chymosin for texture control, proteolysis profiles and sensory risks should be evaluated jointly to avoid bitter-peptide accumulation or excessive gel disruption driven by non-specific hydrolysis.
VIII. Practical Considerations for Research Use and Experimental Optimization
8.1 Standardization and comparability control
(1) Milk matrix consistency:
Fix milk source, protein and fat contents, heat-treatment conditions, and storage time to reduce errors from milk-salt-equilibrium fluctuations.
(2) pH and Ca2+ window scanning:
Establish pH and Ca2+ addition gradients and record clotting time and rheological curves. After locking a reproducible window, proceed to between-group comparisons.
(3) Activity normalization and lot bridging:
Normalize dosing by activity units and include lot-bridging QC to prevent conclusions from being confounded by lot-to-lot activity drift.
8.2 Non-specific proteolysis risk and interpretive boundaries
(1) Excessive dosing or enzyme preparations with higher accompanying protease fractions can increase fragility, fines losses, abnormal drainage, and bitterness risk; validate with proteolysis profiling and microstructural characterization.
(2) “Coagulation delay” in heat-treated milk may arise from altered milk-salt equilibrium and stronger whey-protein–κ-casein interactions; interpretations should separate contributions from site-cleavage kinetics versus aggregation-stage limitations.
IX. Aladdin-Related Products
9.1 Chymosin Related Products
Catalog No. | Product Name | Grade and Purity |
Chymosin | Bioactive, ActiBioPure™, High Performance, EnzymoPure™, from Kluyveromyces lactis; ≥20000 IMCU/g enzyme powder | |
Rennin from calf stomach | ≥20 units/mg protein |
9.2 Chymosin System: Key Reagents Commonly Used for Coagulation-Kinetics Measurement, Activity Evaluation, and Product Characterization
Category | Reagent Name | CAS No. | Workflow Step | Role in the System (Applicable Experiments/Steps) | Use Notes |
Ca2+ control | Calcium chloride (CaCl2) | Milk-salt equilibrium control | Restores reduced coagulation performance in heat-treated or low-Ca systems; supports window scanning for coagulation kinetics and gel-strength development | Optimize via gradients rather than one-step large additions; fix addition method and mixing time | |
Chelation / control | Sodium citrate | Free Ca2+ availability control | Reduces free Ca2+ to delay coagulation or serve as a “Ca2+-dependence” control | Use small-range gradients; avoid excess that compromises comparability | |
pH control | Lactic acid | Acidity/acidification modeling | Builds coagulation time and gel-strength curves across pH conditions; models lactate-driven acidification backgrounds in fermented systems | Use a calibrated pH meter; after acidification, equilibrate temperature before enzyme addition | |
pH control | Sodium hydroxide (NaOH) | pH back-adjustment / optional quench support | Used for pH back-adjustment and, depending on method, constructing quench or color-development conditions | Prepare low-concentration solutions for control; avoid local high pH that can irreversibly denature proteins | |
Buffer system | Tris (tris(hydroxymethyl)aminomethane) | Condition locking | Stabilizes pH in site-cleavage kinetics, κ-casein cleavage assays, and control systems | Fix buffer species/concentration/pH; record temperature because temperature shifts can change pH | |
Buffer system | Sodium acetate | Acidic buffer system | Supports stability/activity window evaluation of chymosin under acidic conditions and related controls | Fix ionic strength; avoid combining with strong chelation systems that alter Ca2+ availability | |
Ionic strength / salt balance | Sodium chloride (NaCl) | Ionic-strength scanning | Probes how ionic strength impacts clotting time, micelle aggregation, and syneresis behavior | Perform salt-gradient mapping first, then lock conditions; standardize handling across same-batch samples | |
Protein quench / deproteinization | Trichloroacetic acid (TCA) | GMP/protein handling | Quenches reactions and precipitates proteins (commonly for GMP analysis in supernatants or for sample clarification) | Check downstream compatibility with strong acid; apply standardized neutralization/dilution after quench | |
Reducing agent | DTT | SDS-PAGE sample prep | Reduces disulfide bonds to improve visualization of band changes before/after κ-casein cleavage in SDS-PAGE | Control concentration and heating; excess can affect some detection systems | |
Reducing agent | β-Mercaptoethanol | SDS-PAGE sample prep | Alternative reducer for SDS-PAGE to improve band resolution of cleavage products | Highly volatile: handle sealed; fix one reducer (β-ME or DTT) per method | |
Denaturing electrophoresis | SDS | SDS-PAGE | Enables SDS-PAGE profiling of κ-casein cleavage products and non-specific proteolysis patterns | Fix formulation and running conditions; avoid excessive salt load that causes smearing | |
Crosslinker | Bis-acrylamide | SDS-PAGE gel casting | Controls pore size and mechanical strength, affecting band resolution | Fix crosslink ratio; same-batch gel preparation reduces inter-batch differences | |
Polymerization initiator | Ammonium persulfate (APS) | SDS-PAGE gel casting | Initiates polymerization and influences pore uniformity and background | Prepare fresh; fix APS/TEMED ratio | |
Polymerization catalyst | TEMED | SDS-PAGE gel casting | Catalyzes polymerization with APS, affecting gel consistency | Control amount; excess accelerates polymerization and can cause pore non-uniformity | |
Electrophoresis buffer | Glycine | Running buffer | Component of Tris-Glycine-SDS running buffer supporting protein separation and comparability | Fix buffer formulation and voltage/temperature control; avoid batch-to-batch formulation drift | |
Gel staining | Coomassie Brilliant Blue R-250 | SDS-PAGE staining | Visualizes κ-casein cleavage and non-specific proteolysis band patterns | Fix staining/destaining times; unify workflow within gel batches | |
Destaining system | Methanol | Stain/destain | Used in Coomassie destaining to improve band clarity | Handle volatility and safety; fix ratios to keep background consistent | |
Destaining system | Acetic acid | Stain/destain | Used in staining/destaining systems and in some sample acidification steps | Fix concentration and time; avoid over-acidification that affects downstream analyses | |
HPLC/LC support | Acetonitrile | HPLC separation | Organic phase for reversed-phase HPLC separation of GMP/peptides (e.g., ripening proteolysis profiling or GMP quantitation) | Standardize gradient and flow rate; use same-batch solvents to reduce drift | |
HPLC support | Trifluoroacetic acid (TFA) | Mobile-phase additive (HPLC) | Improves peak shape and separation stability in reversed-phase HPLC | For LC-MS coupling, evaluate ion-suppression risk; fix concentration | |
HPLC/LC-MS support | Formic acid | Mobile-phase additive (LC-MS) | Supports peptide/GMP analysis under LC-MS conditions | Choose either formic acid or TFA per platform and standardize; avoid mixed use that reduces comparability |
Chymosin is defined by highly specific hydrolysis of the κ-casein Phe105–Met106 site, which weakens the stabilizing surface layer of casein micelles and, under Ca2+-driven conditions, induces micellar aggregation to form a rennet gel network. It is therefore a key tool for cheese processing and for studying phase transitions in milk-protein colloids. Coagulation outcomes are jointly determined by enzyme source and the ratio of clotting activity to proteolytic activity, dose, temperature, pH, effective Ca2+ availability, milk thermal history, and milk composition. A comprehensive evaluation framework is recommended that integrates clotting time, rheological gel-strength build-up curves, whey-separation behavior, and proteolysis profiles, while hardening critical parameter windows into traceable process-control strategies to enable coordinated optimization of texture, yield, and flavor and to improve lot-to-lot consistency.
For more related articles, please see below:
[2] Biochemical reactions commonly used in microbial identification